Insertional Mutagenesis of Candida auris using Agrobacterium tumefaciens
Insertional Mutagenesis of Candida auris using Agrobacterium tumefaciens
批准号:
9808697
负责人:
BRIAN WICKES
金额:
$23.06万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2021-06-30
关键词:
AddressAmmoniumAntibiotic susceptibilityAntibioticsAntifungal AgentsAzolesCandidaCandidate Disease GeneCell SurvivalCellsCenters for Disease Control and Prevention (U.S.)CharacteristicsClinicClinicalCommunicable DiseasesCountryDataDevelopmentDisinfectionDrug TargetingDrug resistanceEssential GenesExposure toFormulationFrequenciesFungi ModelFurnitureFutureGenerationsGenesGenomeGenomic DNAGenomicsGoalsHumanInfectionInsertional MutagenesisLeadLibrariesMammalian CellMapsMattressesMedicalMethodsModelingModificationMorbidity - disease rateMulti-Drug ResistanceMycosesNatural ProductsNatural ResistanceNatureOrganismPatientsPharmaceutical PreparationsPoisonProbabilityPublic HealthRefractoryReportingResearchResistanceResistance developmentRhizobium radiobacterRiskSaccharomyces cerevisiaeSiteSodium ChlorideSpeedStructureSystemTestingUntranslated RNAbasecell transformationdeep sequencingdensitydrug candidatedrug discoveryexhaustfungusimprovedknockout genemortalitynext generationnext generation sequencingnovel sequencing technologynovel strategiespathogenic bacteriapathogenic fungusrapid techniqueresponsescreeningsmall molecule librariestransmission processtreatment choice
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Drug resistance is arguably one of the most pressing problems in infectious disease. Resistance can occur
naturally, where organisms exhbit natural low-level antibiotic susceptibility or it can occur spontaneously after
exposure to antibiotics. Fungi pose special problems to antibiotic development because there are very limited
antibiotic choices for treatment. Many promising lead compounds that are toxic to fungi unfortunately are
toxic to mamals due to the similar eukaryoctic cellular organization. Consequently antifungal development
has always been difficult for fungi. Candida auris is an emerging fungal pathogen that displays a high
frequency of natural resistance to first line antifungal treatment, but also has been shown to develop
resistance to all know antifugals. The extremely rapid spread of this fungus around the world and high
mortality rate (~30-80% depending on country) has amplified known problems in treating systemic mycosis:
the lack of antifungal choices for fungal infections. Most of what we know about antifungal drug research is
derived from studies of non-pathogenic model fungi, such as Saccharomyces cerevisiae, which are
unsuitable as pan-fungal models. To address this issue, we will develop a method that rapidly interrogates
the C. auris genome to reveal genes that are potential antifungal targets by virtue of their function being
essential to cell survival. The major objective of this study will be to develop a way to rapidly and
inexpensively identify these targets. To accomplish this goal we will develop an insertional mutagenesis
system based on the bacterial pathogen, Agrobacterium tumefaciens for C. auris. The first aim will be to
improve the existing Agrobacterium tumefaciens transformation efficiency to yield enough transformants to
produce a saturated insertional mutagenesis map. We will next develop a capture-probe based enrichment
method for recovering insertion site fragments from the predominating non-junctional genomic DNA
background. Finally, we will apply deep sequencing to these enriched fragments to identify each insertion site
and its neighboring flanking genomic DNA, and ultimately assemble a high density insertion map that will be
used to identify genes that are essential for survival, and therefore, potential antifungal targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a rapid, pan fungal diagnostic assay
-
批准号:10552690
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2021
-
负责人:BRIAN WICKES
-
依托单位:
Development of a rapid, pan fungal diagnostic assay
-
批准号:10211503
-
项目类别:
-
资助金额:$45.08万
-
财政年份:2021
-
负责人:BRIAN WICKES
-
依托单位:
Development of a rapid, pan fungal diagnostic assay
-
批准号:10335282
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2021
-
负责人:BRIAN WICKES
-
依托单位:
Pan-Fungal Essential Gene Discovery for Antifungal Targeting
-
批准号:9056983
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2015
-
负责人:BRIAN WICKES
-
依托单位:
Pan-Fungal Essential Gene Discovery for Antifungal Targeting
-
批准号:8970250
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2015
-
负责人:BRIAN WICKES
-
依托单位:
Core--Genomics
-
批准号:6912417
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2005
-
负责人:BRIAN WICKES
-
依托单位:
Congenic strains of serotype A Cryptococcus neoformans
-
批准号:6603508
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2003
-
负责人:BRIAN WICKES
-
依托单位:
Congenic strains of serotype A Cryptococcus neoformans
-
批准号:6843089
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2003
-
负责人:BRIAN WICKES
-
依托单位:
Congenic strains of serotype A Cryptococcus neoformans
-
批准号:6699639
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2003
-
负责人:BRIAN WICKES
-
依托单位:
MATING TYPE AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS
-
批准号:6373899
-
项目类别:
-
资助金额:$11.16万
-
财政年份:1998
-
负责人:BRIAN WICKES
-
依托单位:
MATING TYPE AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS
-
批准号:6170559
-
项目类别:
-
资助金额:$10.83万
-
财政年份:1998
-
负责人:BRIAN WICKES
-
依托单位:
MATING TYPE AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS
-
批准号:6510872
-
项目类别:
-
资助金额:$11.49万
-
财政年份:1998
-
负责人:BRIAN WICKES
-
依托单位:
MATING TYPE AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS
-
批准号:2681730
-
项目类别:
-
资助金额:$6.14万
-
财政年份:1998
-
负责人:BRIAN WICKES
-
依托单位:
MATING TYPE AND VIRULENCE IN CRYPTOCOCCUS NEOFORMANS
-
批准号:2887809
-
项目类别:
-
资助金额:$10.52万
-
财政年份:1998
-
负责人:BRIAN WICKES
-
依托单位:
Core--Genomics
-
批准号:7901536
-
项目类别:
-
资助金额:$5.16万
-
财政年份:--
-
负责人:BRIAN WICKES
-
依托单位:
Core--Genomics
-
批准号:7310217
-
项目类别:
-
资助金额:$7.17万
-
财政年份:--
-
负责人:BRIAN WICKES
-
依托单位:
Core--Genomics
-
批准号:7458687
-
项目类别:
-
资助金额:$7.33万
-
财政年份:--
-
负责人:BRIAN WICKES
-
依托单位:
Core--Genomics
-
批准号:7662478
-
项目类别:
-
资助金额:$5.19万
-
财政年份:--
-
负责人:BRIAN WICKES
-
依托单位:
海外基金